Invesco
CABA icon

Invesco’s Cabaletta Bio CABA Stock Holding History

Invesco’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$751K Buy
241,565
+49,182
+26% +$162K ﹤0.01% 3062
2026
Q1 		$518K Buy
192,383
+3,188
+2% +$8.85K ﹤0.01% 3149
2025
Q4 		$414K Buy
189,195
+66,395
+54% +$165K ﹤0.01% 3271
2025
Q3 		$287K Buy
122,800
+37,969
+45% +$65.1K ﹤0.01% 3436
2025
Q2 		$129K Buy
84,831
+23,156
+38% +$36.1K ﹤0.01% 3614
2025
Q1 		$85.4K Buy
61,675
+48,181
+357% +$103K ﹤0.01% 3652
2024
Q4 		$30.6K Sell
13,494
-371
-3% -$1.3K ﹤0.01% 3727
2024
Q3 		$65.4K Sell
13,865
-1,459
-10% -$8.44K ﹤0.01% 3658
2024
Q2 		$115K Sell
15,324
-729,453
-98% -$8.94M ﹤0.01% 3734
2024
Q1 		$12.7M Sell
744,777
-653,165
-47% -$14M ﹤0.01% 1689
2023
Q4 		$31.7M Buy
1,397,942
+543,899
+64% +$9.14M 0.01% 1201
2023
Q3 		$13M Sell
854,043
-2,846
-0.3% -$38.9K ﹤0.01% 1589
2023
Q2 		$11.1M Buy
+856,889
New +$9.3M ﹤0.01% 1745

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Invesco's CABA Position: Q2 2026 in Review

Invesco increased its Cabaletta Bio (CABA) stake by 26% in Q2 2026, buying an estimated $162K and bringing the position to 241,565 shares worth $751K. The position accounts for ﹤0.01% of the portfolio, ranked #3062.

Invesco first reported a position in CABA in Q2 2023 and has held it in 13 quarters since. The position peaked at $31.7M in Q4 2023. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Invesco held 241,565 shares of Cabaletta Bio worth $751K as of Q2 2026.
  • Invesco bought 49,182 Cabaletta Bio shares in Q2 2026, an estimated $162K.
  • Cabaletta Bio made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3062 holding.
  • Invesco first reported a position in Cabaletta Bio in Q2 2023 and has held it in 13 quarters since.
  • Invesco's Cabaletta Bio position peaked at $31.7M in Q4 2023.
  • 140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.